Supplementation with BHB salts can decrease migraine frequency by 51%
That was the conclusion of a pilot study presented at the 18th Congress of the International Headache Society. The study looked migraine frequency after a month of supplementation with the ketone body, beta –hydroxybutyrate (BHB). The participants consisted of four females and one male who had refractory migraines, defined as having an average pretreatment migraine frequency between 6-24 migraines a month.
The BHB supplement, in salt form, was given at a dose of 10 mg twice a day on top of a normal diet. During the one month on the supplement, there was an average reduction of 51% in migraine days compared to baseline. The migraine days per month went from a pretreatment an average of 16.25 day down to 8 migraine days during the month.
Granted this was a small study with only five participants, but the 51% reduction in only one month is impressive. Especially since Topiramate, probably the most prescribed medication for migraine prevention, also showed about a 50% reduction in migraine frequency.
The good news is that there is a BHB salt supplement that is commercially available without a physician’s prescription. Click here to find out more about the ketone supplement.* For more information on why ketones may be beneficial in patients with migraines please see prior blogs.
Gross, E. (2017). Preliminary Data on Exogenous Ketone Bodies in Migraine Prevention. 18th Congress of the Internation Headache Society, (PO-01-069).
Silberstein SD, (2004). Topiramate in migraine prevention, results of a large controlled trial. Arch Neurol. 61:490–5.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to are not intended to diagnose prevent treat or cure any disease. If you are under medical supervision for any allergy, disease, taking prescription medications or you are breastfeeding contact your medical provider before adding any new supplements to your daily regimen